Lipigon Pharmaceuticals AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-15 | Lipigon Pharmaceuticals AB | Eva Pinotti Lindqvist | Member of the Board of Directors | Exercise increase | 300 000 | 0,3 | SEK | 90 000 | 2023-12-12 |
| 2023-12-16 | Lipigon Pharmaceuticals AB | Lars Öhman | Chairman of the Board of Directors | Exercise increase | 343 200 | 0,3 | SEK | 102 960 | 2023-12-13 |
| 2023-12-16 | Lipigon Pharmaceuticals AB | Lars Öhman | Chairman of the Board of Directors | Exercise decrease | 343 200 | 0,3 | SEK | 102 960 | 2023-12-13 |
| 2023-12-18 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 10 500 | 0,3 | SEK | 3 150 | 2023-12-14 |
| 2023-12-18 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 10 500 | 0,3 | SEK | 3 150 | 2023-12-14 |
| 2023-12-20 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 311 804 | 0,432 | SEK | 134 771,417 | 2023-12-19 |
| 2024-03-21 | Lipigon Pharmaceuticals AB | Hugo Petit | Chief Financial Officer (CFO) | Acquisition | 200 000 | 0,08 | SEK | 16 000 | 2024-03-20 |
| 2024-04-21 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 300 852 | 0,337 | SEK | 101 293,258 | 2024-04-18 |
| 2024-04-26 | Lipigon Pharmaceuticals AB | Hugo Petit | Chief Financial Officer (CFO) | Acquisition | 263 000 | 0,06 | SEK | 15 780 | 2024-04-25 |
| 2024-04-29 | Lipigon Pharmaceuticals AB | Stefan Pierrou | Other member of the company's administrative, management or supervisory body | Acquisition | 263 572 | 0,06 | SEK | 15 814,32 | 2024-04-25 |
| 2024-04-30 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 790 715 | 0,06 | SEK | 47 442,9 | 2024-04-25 |
| 2024-06-04 | Lipigon Pharmaceuticals AB | Eva Pinotti Lindqvist | Member of the Board of Directors | Exercise increase | 150 000 | 0,2 | SEK | 30 000 | 2024-06-02 |
| 2024-06-04 | Lipigon Pharmaceuticals AB | Eva Pinotti Lindqvist | Member of the Board of Directors | Exercise decrease | 150 000 | 0,2 | SEK | 30 000 | 2024-06-02 |
| 2024-06-05 | Lipigon Pharmaceuticals AB | Jessica Marie Martinsson | Member of the Board of Directors | Exchange decrease | 33 000 | 0,2 | SEK | 6 600 | 2024-06-02 |
| 2024-06-06 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 52 500 | 0,2 | SEK | 10 500 | 2024-06-02 |
| 2024-06-06 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 52 500 | 0,2 | SEK | 10 500 | 2024-06-02 |
| 2024-06-13 | Lipigon Pharmaceuticals AB | Fredrik Lindgren | Member of the Board of Directors | Exercise increase | 900 000 | 0,2 | SEK | 180 000 | 2024-06-06 |
| 2024-06-13 | Lipigon Pharmaceuticals AB | Fredrik Lindgren | Member of the Board of Directors | Exercise decrease | 900 000 | 0,2 | SEK | 180 000 | 2024-06-06 |
| 2024-06-18 | Lipigon Pharmaceuticals AB | Stefan Nilsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 136 056 | 0,286 | SEK | 38 950,112 | 2024-06-16 |
| 2024-08-22 | Lipigon Pharmaceuticals AB | Fredrik Lindgren | Member of the Board of Directors | Acquisition | 143 511 | 0,94 | SEK | 134 900,34 | 2024-08-21 |